Confusable diagnoses · PANCE / PANRE

Basal Cell Carcinoma vs Squamous Cell Carcinoma

Written & clinically reviewed by Ryan Busch, PA-C · Updated August 2026 · Report an error

Basal Cell Carcinoma and Squamous Cell Carcinoma are easy to mix up on the boards. Here's a side-by-side comparison — presentation, workup, imaging, and first-line treatment — drawn from our full outlines.

Basal Cell Carcinoma vs Squamous Cell Carcinoma at a glance

  • Basal Cell Carcinoma: Most common human cancer; slow-growing locally invasive tumor of basal keratinocytes driven by UV-induced PTCH/Hedgehog mutations.
  • Squamous Cell Carcinoma: Second most common skin cancer; UV-driven keratinocyte malignancy with real metastatic potential, especially in immunosuppressed.

Try two board-style questions on Basal Cell Carcinoma vs Squamous Cell Carcinoma

Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.

Question 1DermatologyMedium
A 72-year-old fair-skinned man presents for a slowly enlarging lesion on the side of his nose that he first noticed over a year ago, describing it as a "pimple that never healed" that occasionally bleeds when he washes his face. He has a long history of outdoor work and a prior actinic keratosis. On examination there is a 7 mm pearly translucent papule with a rolled border, arborizing telangiectasias, and central crusting. There is no regional lymphadenopathy. Which of the following is the most appropriate next diagnostic test to confirm the diagnosis?
  • ACT scan of the face and neck
  • BSentinel lymph node biopsy
  • CPunch or shave skin biopsy
  • DDermoscopic examination
Reveal answer & full explanation
Correct answer: C — Punch or shave skin biopsy
  • ACT scan of the face and neck
  • BSentinel lymph node biopsy
  • CPunch or shave skin biopsy✓
  • DDermoscopic examination

Why Punch or shave skin biopsy is correct

  • The pearly translucent papule with a rolled border, arborizing telangiectasias, and central crusting and ulceration on a sun-exposed nose of an older fair-skinned adult is the classic picture of nodular basal cell carcinoma.
  • Tissue diagnosis is required for any suspected cutaneous malignancy. A shave or punch biopsy provides histopathologic confirmation (basaloid cells in palisading nests with retraction artifact and myxoid stroma) and identifies the subtype, which directs management such as Mohs surgery for high-risk facial/H-zone or morpheaform tumors.

Why the others are wrong

  • CT scan of the face and neck — cross-sectional imaging reserved for advanced or recurrent tumors with suspected perineural invasion or deep involvement, not for a typical small primary BCC.
  • Sentinel lymph node biopsy — unnecessary because BCC metastasizes in fewer than 0.05% of cases. Nodal staging belongs to the workup of melanoma or high-risk SCC, not BCC.
  • Dermoscopic examination — supports the clinical impression (arborizing vessels, blue-gray nests) but cannot establish a tissue diagnosis or subtype, so it never substitutes for biopsy in a suspected malignancy.
Question 2DermatologyEasy
A 72-year-old male with multiple actinic keratoses has a firm, indurated, 1.8 cm ulcerated nodule with raised, everted borders on his right cheek. It bleeds easily on contact. There is no regional lymphadenopathy. Which of the following is the most likely diagnosis?
  • AActinic keratosis
  • BBasal cell carcinoma
  • CCutaneous squamous cell carcinoma
  • DKeratoacanthoma
Reveal answer & full explanation
Correct answer: C — Cutaneous squamous cell carcinoma
  • AActinic keratosis
  • BBasal cell carcinoma
  • CCutaneous squamous cell carcinoma✓
  • DKeratoacanthoma

Why cutaneous squamous cell carcinoma is correct

  • Firm indurated ulcerated nodule with raised, everted borders on the sun-exposed face in an elderly patient with actinic field changes is classic for cutaneous squamous cell carcinoma (cSCC)
  • Treatment: biopsy to confirm, then Mohs micrographic surgery for facial location (head and neck, ears) — confirms complete excision with margin control while minimizing tissue removal on cosmetically sensitive areas
  • Standard excision (4–6 mm margins) is acceptable for low-risk tumors on trunk and extremities

Why the others are wrong

  • Actinic keratosis — a precancerous, scaly erythematous macule/papule with a rough "sandpaper" feel, not a firm indurated ulcerated nodule; induration, ulceration, and easy bleeding signal progression to invasive cSCC
  • Basal cell carcinoma — typically a pearly, translucent papule with rolled (not everted) borders and telangiectasias that ulcerates centrally ("rodent ulcer"); it lacks the firm everted-border nodular morphology and rarely arises directly within actinic keratoses
  • Keratoacanthoma — a rapidly growing dome-shaped nodule with a central keratin-filled crater that often regresses spontaneously, rather than a persistent ulcerated lesion with raised everted borders that bleeds on contact

Additional high-yield points

  • High-risk cSCC features indicating potential nodal workup: size over 2 cm, depth over 6 mm or invasion beyond subcutaneous fat, poorly differentiated, perineural invasion, immunosuppressed patient
  • Cemiplimab (anti-programmed cell death protein 1 (PD-1)): approved for locally advanced or metastatic cSCC
🔒 Free preview limit reached

Keep comparing — start your free trial

You've used your 2 free previews. Create your free account to see the full Basal Cell Carcinoma vs Squamous Cell Carcinoma comparison — plus all 514 diagnosis outlines, 7,200+ board-style questions, and an AI tutor. Your 7-day free trial includes everything, no credit card required.

Start your 7-day free trial → Sign in
Free to start · No credit card · Cancel anytime

Side-by-side comparison

FeatureBasal Cell CarcinomaSquamous Cell Carcinoma
At a glanceMost common human cancer; slow-growing locally invasive tumor of basal keratinocytes driven by UV-induced PTCH/Hedgehog mutations.Second most common skin cancer; UV-driven keratinocyte malignancy with real metastatic potential, especially in immunosuppressed.
Classic presentationPearly translucent nodule with rolled border, telangiectasias, and central ulcer on a sun-exposed area of an older fair-skinned adult.; Often asymptomatic; patient notices 'pimple' or 'sore that won't heal' for months to years; Occasional bleeding with minor trauma; rarely painful unless ulcerated/infected; Nodular BCC (most common,…Hyperkeratotic indurated nodule with central ulceration on sun-damaged skin of an older adult, often arising from a pre-existing actinic keratosis.; Often asymptomatic; new growth, non-healing 'sore', or growth in a chronic scar/ulcer; Tenderness, bleeding, crusting; Pain, paresthesia, motor weakness → perineural invasion; Bowen disease…
Workup / key labsHistopathologic confirmation of basaloid tumor cells in palisading nests with retraction artifact and myxoid stroma.; Tissue diagnosis required — skin biopsy (shave or punch); Histopathology subtype determines management (nodular, superficial, morpheaform/infiltrative, basosquamous, micronodular)Histopathologic confirmation; AJCC 8th edition staging + NCCN/BWH risk stratification; Skin biopsy (shave, punch, or excisional) — tissue diagnosis required; Histopathology determines depth, differentiation (well/moderate/poor), perineural invasion, and high-risk features
ImagingCT/MRI only for advanced or recurrent tumors with suspected perineural invasion or deep tissue involvement; Routine imaging not indicated for typical primary BCCLymph node ultrasound + FNA if palpable lymphadenopathy or high-risk tumor; CT/MRI for large tumors, perineural invasion symptoms, deep tissue/bone involvement; PET/CT for staging in advanced disease; Sentinel lymph node biopsy considered for high-risk SCC (>2 cm, >6 mm depth, poor differentiation, perineural invasion,…
First-line treatmentSurgical excision with 4 mm margins for low-risk primary BCC (cure rate ~95%); Mohs micrographic surgery (preferred for high-risk BCC): face (especially H-zone — central face, periocular, periauricular, perinasal), morpheaform/infiltrative subtypes, recurrent tumors, large tumors (>2 cm), positive margins after standard excision — cure…Low-risk primary cutaneous SCC: surgical excision with 4-6 mm clinical margins (cure rate >95%); Mohs micrographic surgery (preferred for high-risk SCC): face/H-zone, ears, lips, genitalia, perineural invasion, recurrent, >2 cm, depth >6 mm, poor differentiation, immunosuppressed host; ED&C for small (<1 cm) low-risk SCC in situ on…

Drill Basal Cell Carcinoma vs Squamous Cell Carcinoma questions on FirstPassPA

Turn this comparison into retention. 7,200+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Answer the 2 free questions above → Get today's free question →

Full outlines

Basal Cell Carcinoma Squamous Cell Carcinoma All 514 diagnoses

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.